New Executive Chair brings decades of operational and board experience from Pharma, Biotech and Venture Capital to Theolytics OXFORD, England, March 21, 2024 /PRNewswire/ — Theolytics, a biotechnology company developing category changing cancer therapies in the form of oncolytic viruses,…